Pharmacokinetic-pharmacodynamic modeling of the anticonvulsant and electroencephalogram effects of phenytoin in rats.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  1998-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 9454785
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetic-pharmacodynamic modelling in pre-clinical investigations: principles and perspectives

  2011cited by this paper
• Diphenylhydantoin potentiates the EEG and behavioural effects induced by N-methyl-D-aspartate antagonists in rats

  2005cited by this paper
• LEIDEN/AMSTERDAM CENTER FOR DRUG RESEARCH

  1994cited by this paper
• The In Vivo Study of Drug Action

  1994cited by this paper
• Anticonvulsant Activities of 4–Bromobenzaldehyde Semicarbazone

  1994cited by this paper
• Characterization of the pharmacodynamics of several antiepileptic drugs in a direct cortical stimulation model of anticonvulsant effect in the rat.

  1994cited by this paper
• Profile of Anticonvulsant Activity and Minimal Toxicity of Methyl 4‐[(p‐Chlorophenyl)amino]‐6‐Methyl‐2‐Oxo‐Cyclohex‐3‐En‐l‐Oate and Some Prototype Antiepileptic Drugs in Mice and Rats

  1993cited by this paper
• Anticonvulsant efficacy and adverse effects of phenytoin during chronic treatment in amygdala-kindled rats.

  1993cited by this paper
• Generalized pharmacokinetic modeling for drugs with nonlinear binding: I. Theoretical framework

  1993cited by this paper
• Effect of barbiturate therapy on phenytoin pharmacokinetics

  1993cited by this paper
• [The clinical interpretation of the concentrations of anticonvulsants in the blood].

  1993cited by this paper
• Properties of the convulsive threshold determined by direct cortical stimulation in rats.

  1992cited by this paper
• Rational use of antiepileptic drug levels.

  1992cited by this paper
• Electroencephalogram Effect Measures and Relationships Between Pharmacokinetics and Pharmacodynamics of Centrally Acting Drugs

  1992cited by this paper
• Modelling of the pharmacodynamics and pharmacodynamic interactions of CNS active drugs.

  1992cited by this paper
• Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration‐EEG effect relationship

  1992cited by this paper
• A system approach to pharmacodynamics. III: An algorithm and computer program, COLAPS, for pharmacodynamic modeling.

  1991cited by this paper
• Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity.

  1991cited by this paper
• [Therapeutic drug monitoring of phenytoin].

  1990cited by this paper
• Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats.

  1990cited by this paper
• Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of heptabarbital using aperiodic EEG analysis

  1990cited by this paper
• Therapeutic Drug Monitoring of Phenytoin Rationale and Current Status

  1990cited by this paper
• Phannacokinetic‐pharmacodynamic modelling of the anticonvulsant effect of oxazepam in individual rats

  1990cited by this paper
• A micromethod for the estimation of free levels of anticonvulsant drugs in serum.

  1989cited by this paper
• Determination of the threshold for convulsions by direct cortical stimulation.

  1989cited by this paper
• Phenytoin reduces excitatory synaptic transmission and post-tetanic potentiation in the in vitro hippocampus.

  1988cited by this paper
• Properties of phenytoin binding sites in the rat brain: regional distribution and postnatal development.

  1988cited by this paper
• Kinetic analysis of phenytoin disposition in rats with experimental renal and hepatic diseases.

  1988cited by this paper
• Mechanisms of calcium channel block by phenytoin.

  1988cited by this paper
• Quantitative relationships between dynamics and kinetics of drugs: a systems dynamics approach.

  1984cited by this paper
• Phenytoin pharmacokinetics in catamenial epilepsy

  1984cited by this paper
• Review on correlation between pharmacologic response and drug disposition.

  1984cited by this paper
• Phenytoin Michaelis-Menten Pharmacokinetics in Caucasian Paediatric Patients

  1983cited by this paper
• Kinetics of pharmacologic response.

  1982cited by this paper
• Noncompartmental Analysis Based on Statistical Moment Theory

  1982influential reference
• Understanding the Dose-Effect Relationship

  1981cited by this paper
• Phenytoin: pharmacokinetics and clinical therapeutics.

  1981cited by this paper
• Brain uptake of phenytoin, phenobarbital, and diazepam.

  1979cited by this paper
• Predicting Phenytoin Dose—A Revised Nomogram

  1979influential reference

• Stochastic target-mediated drug disposition model based on birth-death process and its parameter inference using approximate Bayesian computation-MCMC

  2021cites this paper
• Use of IV fosphenytoin pharmacokinetics to determine the loading dose for a clinical trial of canine status epilepticus

  2015cites this paper
• Preparation and evaluation of carbamazepine loaded fibrous electrospun mats of starch

  2015cites this paper
• Pharmacokinetic -Pharmacodynamic (PK -PD) Model ing: A Review

  2014cites this paper
• Porous Starch: a Novel Carrier for Solubility Enhancement of Carbamazepine

  2013cites this paper
• Incorporation of Physiologically Based Pharmacokinetic Modeling in the Evaluation of Solubility Requirements for the Salt Selection Process: A Case Study Using Phenytoin

  2013cites this paper
• Convulsant activity and pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of gemifloxacin in rats.

  2010cites this paper
• Pharmacokinetic–pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age

  2010cites this paper
• Long‐lasting target binding and rebinding as mechanisms to prolong in vivo drug action

  2010cites this paper
• Selection between Michaelis–Menten and target-mediated drug disposition pharmacokinetic models

  2010influential citation
• Comparison of in vitro and in vivo developmental toxicity and pharmacokinetics of phenytoin in the rat.

  2008cites this paper
• Nonlinear mixed effects pharmacokinetic/pharmacodynamic analysis of the anticonvulsant ameltolide (LY201116) in a canine seizure model.

  2008cites this paper
• Region-Specific Overexpression of P-glycoprotein at the Blood-Brain Barrier Affects Brain Uptake of Phenytoin in Epileptic Rats

  2007influential citation
• The role of the blood-brain barrier and multidrug transporters in pharmacoresistant epilepsy : studies in a rat model for temporal lobe epilepsy

  2007cites this paper
• Pharmacokinetic-pharmacodynamic modelling of the electroencephalogram effect of imipenem in rats with experimental hypovolaemia or endotoxaemia.

  2004cites this paper
• Simultaneous central nervous system distribution and pharmacokinetic–pharmacodynamic modelling of the electroencephalogram effect of norfloxacin administered at a convulsant dose in rats

  2004cites this paper
• Pharmacokinetic-Pharmacodynamic Modeling of the Electroencephalogram Effect of Norfloxacin in Rats

  2003cites this paper
• Effects of classical antiepileptics on thresholds for phenomena induced by cortical stimulation in rats

  2002influential citation
• Influence of Hypovolemia on the Pharmacokinetics and Electroencephalographic Effect of &ggr;-Hydroxybutyrate in the Rat

  2002cites this paper
• Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.

  2002cites this paper
• Mathematical modelling and quantitative methods.

  2002cites this paper
• P-glycoprotein inhibitors enhance saturable uptake of idarubicin in rat heart: pharmacokinetic/pharmacodynamic modeling.

  2002influential citation
• Pharmacokinetic‐pharmacodynamic modelling in the early development phase of anti‐psychotics: a comparison of the effects of clozapine, S 16924 and S 18327 in the EEG model in rats

  2001cites this paper
• Relationship between gamma‐hydroxybutyrate plasma concentrations and its electroencephalographic effects in the rat

  2001influential citation
• Stanley Effect of Imipenem in Healthy Rats Modeling of the Electroencephalogram Pharmacokinetic-Pharmacodynamic

  2001cites this paper
• Pharmacokinetic-Pharmacodynamic Modeling of Electroencephalogram Effect of Imipenem in Rats with Acute Renal Failure

  2001cites this paper
• Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole.

  2001cites this paper
• Pharmacokinetic-Pharmacodynamic Modeling of the Electroencephalogram Effect of Imipenem in Healthy Rats

  2001cites this paper
• Pharmacokinetic-pharmacodynamic correlation of lamotrigine, flunarizine, loreclezole, CGP40116 and CGP39551 in the cortical stimulation model.

  2000cites this paper
• Comparison of in vitro and in vivo Developmental Toxicity and Pharmacokinetics of Phenytoin in the Rat

  2000cites this paper
• Pharmacodynamic interaction between phenytoin and sodium valproate changes seizure thresholds and pattern

  1998cites this paper
• Estimating Potency for the Emax-Model Without Attaining Maximal Effects

  1998cites this paper
• Effects of repeated seizure induction on seizure activity, post-ictal and interictal behavior.

  1998cites this paper
• Modelling of the pharmacodynamic interaction between phenytoin and sodium valproate

  1998cites this paper